Chemoradiotherapy of squamous cell anal cancer

Abstract

Squamous cell carcinoma of the anal canal is a rare disease and is no more than 1.7-2% of the annual cancer incidence. Chemoradiation therapy - the standard modern treatment of squamous cell anal cancer. Short-term recurrence-free period of the new approaches to the treatment of anal cancer, in particular to the new regimes chemoradiotherapy.

Keywords

anal cancer / chemoradiotherapy

References

[1] Siegel R., Naishadham D., Jemal A. Cancer statistics, 2013. Cancer J. Clin. 2013; 63: 11-30.

[2] De Vuyst H., Clifford G.M., Nascimento M.C. et al. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int. J. Cancer. 2009;124: 1626-36.

[3] Daling J.R., Madeleine M.M., Johnson L.G. et al. Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer. 2004; 101: 270-80.

[4] Frisch M., Glimelius B., van den Brule A.J. et al. Sexually transmitted infection as a cause of anal cancer. N. Engl. J. Med. 1997; 337: 1350-8.

[5] Uronis H.E., Bendell J.C. Anal cancer: an overview. Oncologist. 2007; 12: 524-34.

[6] Ryan D.P, Compton C.C., Mayer R.J. Carcinoma of the anal canal. N. Engl. J.Med. 342: 2000; 792-800.

[7] Benson A.B. 3rd et al. Anal carcinoma, version 2.2012: featured updates to the NCCN guidelines. J. Natl. Compr. Canc. Netw. 2012; 10: 449-54.

[8] Cacheux W., Lievre A., De La Rochefordiere A., Dieumegard B., Cvitkovic F., Labib A. et al. Chemotherapy in the treatment of anal canal carcinoma. Dig. Liver Dis. 2012; 44: 803-11.

[9] Causey M.V. et al. Chemotherapy for epidermoid carcinoma of the anal canal: An NSQIP assessment of short-term outcomes. J. Surg. Res. 2012; 177: 235-40.

[10] Ortholan C., Ramaioli A., Peiffert D. et al. Anal canal carcinoma: early - stage tumors № 10 mm (T1 or Tis): therapeutic options and original pattern of local failure after radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 2005; 62: 479-85.

[11] Das P., Crane C., Ajani J. Current treatment of localized anal carcinoma. Curr. Opin. Oncol. 2007; 19: 396-400.

[12] Buchs N.C., Allal A.S., Morel P., Gervaz P. Prevention, chemoradiation and surgery for anal cancer. Expert Rev Anticancer Ther. 2009; 9: 483-9.

[13] Papillon J., Montbarbon J.F. Epidermoid carcinoma of the anal canal: A series of 276 cases. Dis. Colon Rect. 1987; 30: 324-33.

[14] Nigro N.D. The force of change in the management of squamous cell cancer of the anal canal. Dis. Colon Rect. 1991; 34: 482-6.

[15] Хрущев М.М., Симакина Е.П., Райфель Б.А. Лучевая терапия эпидермоидного рака прямой кишки. Медицинская радиология. 1977; 8: 19-25.

[16] Кныш В.И., Тимофеев Ю.М. Злокачественные опухоли анального канала. М.: РОНЦ им. Н.Н. Блохина; 1997.

[17] Martenson J.A., Gunderson L.L. External radiation therapy without chemotherapy in the management of anal cancer. Canser. 1993; 71: 1736-40.

[18] Papillon J., Montbarbon J.F., Gerard J.P et al. Interstitial curietherapy in the conservative treatment of anal and rectal cancers. Int. J. Radiat. Oncol. Biol. Phys.1989; 17: 1161-9.

[19] Papillon J. Effectiveness of combined radio-chemotherapy in the management of epidermoid carcinoma of the anal canal. Int. J. Radiat. Oncol. Biol. Phys. 1990; 19: 1217-8.

[20] Wagner J.P, Mahe M.A., Romestaing P. et al. Radiation therapy in the conservative treatment of carcinoma of the anal canal. Int. J. Radiat. Oncol. Biol. Phys. 1994; 29: 17-23.

[21] Nigro N.D., Vaitkevichus V.K., Considine B. Combined therapy for cancer of the anal canal. Dis. Colon Rect. 1974; 27: 763-6.

[22] UKCCR. Anal cancer trial working party. Epidermoid anal cancer: results from the UKCCR randomized trial of radiotherapy alone versus radiotherapy, 5-FU and mitomycin. Lancet. 1996; 348: 1049-54.

[23] Bartelink H., Roelofsen F., Eschwege F., Rougier P., Bosset J.F., Gonzalez D.G. et al. Concomitant radiotherapy and chemiotherapy is superior to radiotherapy alone in the treatment of the locally advanced anal cancer: results of the phase III randomized trial of EORTC radiotherapy and gastrointestinal groups. J. Clin. Oncol. 1997; 15: 2040-9.

[24] Flam M., John M., Pajak.F. et al. Role of mitomycin in combination with fluoruracil and radiotherapy and on salvage chemoradiation in the definitive non-surgical treatment of epidermoid carcinoma of the anal canal: results of the phase III randomized intergroup study. J. Clin. Oncol. 1996; 14(9): 2527-39.

[25] Conroy T., Ducreux M., Lemanski C. et al. Treatment intensification by induction chemotherapy (ICT) and radiation dose escalation in locally advanced squamous cell anal canal carcinoma (LAAC): Definitive analysis of the intergroup ACCORD 03 trial (abstract). J. Clin. Oncol. 2009; 27 (Suppl 15s): 4033.

[26] Zilli T., Schick U., Ozsahin M., Gervas P., Roth A.D., Allas A.S. Nodenegative T1-T2 anal cancer: Radiotherapy alone or concomitant chemoradiotherapy? Radiother Onol. 2012; 102: 62-7.

[27] Graf R., Wust P., Hildebrandt B. et al. Impact of overall treatment time on local control of anal cancer treated with radiochemotherapy. Oncology. 2003;65: 14-22.

[28] Вazan J.G., Hara W., Hsu A. et al. Intensity-modulated radiation therapy versus conventional radiation therapy for squamous cell carcinoma of the anal canal. Cancer. 2011; 117: 3342.

[29] Ajani J.A., Winter K.A., Gunderson L.L. et al. Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial. J.AM.A. 2008; 299: 1914-21.

RIGHTS & PERMISSIONS

Eco-Vector